Ketamine on Acute Pain in Females and Males

PHASE4CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Mouth and Tooth DiseasesTooth, Impacted
Interventions
DRUG

Placebo males

Intravenous saline bolus (Placebo-control) males

DRUG

Ketamine 0,1 mg/kg males

0,1 mg/kg ketamine iv bolus males

DRUG

Ketamine 0,3 mg/kg males

0,3 mg/kg ketamine iv bolus males

DRUG

Ketamine 0,5 mg/kg males

0,5 mg/kg ketamine iv bolus males

DRUG

Placebo females

Intravenous saline bolus (Placebo-control) females

DRUG

Ketamine 0,1 mg/kg females

0,1 mg/kg iv bolus ketamine females

DRUG

Ketamine 0,3 mg/kg females

0,3 mg/kg iv bolus ketamine females

DRUG

Ketamine 0,5 mg/kg females

0,5 mg/kg iv bolus ketamine females

Trial Locations (1)

NO-0407

Department of Oral and Maxillofacial Surgery, Ullevaal University Hospital, Oslo

All Listed Sponsors
collaborator

University of Oslo

OTHER

lead

Ullevaal University Hospital

OTHER

NCT00232492 - Ketamine on Acute Pain in Females and Males | Biotech Hunter | Biotech Hunter